REDHILL BIOPHARMA LTD. Net Fee Amt
REDHILL BIOPHARMA LTD. (RDHL) had Net Fee Amt of $3.62 thousand as of 2026-07-01, per its F-3 filed 2026-07-02.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-07-02
- 2026-07-01: Net Fee Amt $3.62K.
| Period end | Net Fee Amt |
|---|---|
| 2026-07-01 | $3.62K F-3 · filed 2026-07-02 |